TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

Benzinga Logo Benzinga • •By Prnewswire
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking lead investors for a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for securities fraud. The company faced an SEC trading suspension in November 2025 after its stock price spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors who purchased securities between October 21-November 12, 2025, are encouraged to join the lawsuit by February 17, 2026.

Insights
FIG   positive

Cloud-based design platform challenging Adobe, with 45% growth in high-value customers and expected revenue CAGR of 27% from 2024 to 2027


MCTA   negative

The company is the subject of a securities fraud lawsuit, faced an SEC trading suspension, and is alleged to have made false and misleading statements to the market. The stock price spike was allegedly driven by a promotion scheme rather than legitimate business developments, resulting in investor losses.